-
<![CDATA[Spotlighting the Top 10 FDA Oncology Approvals in 2025]]>
27 Dec 2025 16:09 GMT
… trials (NCT02940262 and NCT02918357) supported the approval.13 Each trial … Treanda) and rituximab (Rituxan) received FDA approval as a treatment … in antihypertensive medications by at … Pharmaceuticals announces FDA approval of CAMCEVI ETM for the treatment …
-
<![CDATA[Pirtobrutinib Improves PFS in Treatment-Naive CLL/SLL ]]>
09 Dec 2025 14:41 GMT
… survival (PFS) vs bendamustine (Treanda) plus rituximab (Rituxan; BR) … open-label phase 3 trial enrolled 282 patients … a significantly longer median treatment duration for pirtobrutinib (32 … receiving BR. Furthermore, treatment discontinuation due to TEAEs …
-
<![CDATA[Indirect Comparison Supports Zanubrutinib Monotherapy in CLL/SLL Care]]>
31 Jan 2026 00:29 GMT
… in the Clinical Research Division, medical director of Cellular Immunotherapy, … also evaluated treatment-related adverse effects (TRAEs) across the trial populations.
… the SEQUOIA trial improved with zanubrutinib vs bendamustine (Treanda) plus rituximab …
-
<![CDATA[Pirtobrutinib Wins Traditional FDA Approval in CLL and SLL]]>
03 Dec 2025 19:41 GMT
… Rituxan; IR) or bendamustine (Treanda) plus rituximab (BR). Notably … ;2 trial whose disease progressed following treatment with a …
Wierda is professor, medical director, and CLL … www.fda.gov/drugs/;resources-information-approved-drugs/fda-grants- …
-
Unpacking the Latest Options Trading Trends in Teva Pharmaceutical Indus
30 Sep 2025 20:18 GMT
… has a portfolio of innovative medicines and biosimilars in three main … , and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract … US-based generic and specialty drug distributor.
After a thorough review …
-
<![CDATA[Determining Fitness Is Key in Mantle Cell Lymphoma Treatment Selection]]>
23 Sep 2025 21:53 GMT
… combinations that include bendamustine (Treanda) and rituximab (Rituxan) … Medicine (Hematology) at Yale University.
Transcript:
The current treatment … changed among most lymphoma doctors. That is based … although we have clinical trials ongoing here, so we …
-
Teva Innovative Portfolio and Consistent Execution of Pivot to Growth Strategy Deliver Third Consecutive Year of Growth; Pipeline Positioned to Unlock Significant Value Potential
28 Jan 2026 12:00 GMT
… FDA approved AUSTEDO XR as a one pill, once-daily treatment … generic and innovative medicines and OTC pharmaceutical products from Teva … control regulations and remedial actions taken to …
725
518
40%
BENDEKA/TREANDA
35
41
(14%)
COPAXONE
…
-
Pirtobrutinib Improves PFS in Treatment-Naïve CLL/SLL Without 17p Deletions
08 Sep 2025 18:25 GMT
… 313 trial (NCT05023980) that evaluated pirtobrutinib monotherapy vs bendamustine (Treanda) plus … consistent with previously reported trials across various treatment settings.
"The … study [NCT05254743], at upcoming medical meetings and preparing global …
-
A Glimpse of Teva Pharmaceutical Indus's Earnings Potential
29 Jul 2025 17:23 GMT
… has a portfolio of innovative medicines and biosimilars in three main … , and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract … -based generic and specialty drug distributor.
Teva Pharmaceutical Indus's Financial …
-
Treanda (bendamustine) and cost
30 May 2025 14:40 GMT
… and your doctor will discuss Treanda in regard to your treatment. The insurance … your doctor or another healthcare professional before taking any medication. The drug information …
About
© 1995-2026